ClinicalTrials.Veeva

Menu

Sofia hCG FIA Field Study

Q

Quidel

Status

Completed

Conditions

Pregnancy, Early Detection

Treatments

Device: Sofia hCG FIA

Study type

Observational

Funder types

Industry

Identifiers

NCT01803113
CS-0144-01

Details and patient eligibility

About

The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.

Full description

Subjects presenting for pregnancy testing will provide urine specimens that will be tested with the Sofia hCG FIA test and the comparator pregnancy test that will detect levels of hCG of 20mIU as positive for pregnancy.

Enrollment

975 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female subjects of childbearing age, who are being screened for pregnancy and who have signed the informed consent

Exclusion criteria

  • Subject is post-menopausal.
  • Subject within the past six weeks has experienced any of the following: delivered a newborn; had an abortion or a natural termination (miscarriage); or, received hCG supplements.
  • Subject has had a hysterectomy.
  • Unable to understand and consent to participation.

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems